Status:
UNKNOWN
Vietnam Cryptococcal Retention in Care Study - Version 2.1
Lead Sponsor:
National Hospital for Tropical Diseases, Hanoi, Vietnam
Collaborating Sponsors:
Centers for Disease Control and Prevention
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Conditions:
HIV/AIDS
Cryptococcal Meningitis
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter prospective cohort evaluation of the implementation of a cryptococcal antigen (CrAg) screening program at selected outpatient HIV clinics (OPCs) and network laboratories in Vietn...
Detailed Description
The project will be implemented in 2 phases; Phase 1: From August 2015 to March 2017 \[projected\], HIV-infected patients who present for HIV care and undergo CD4 testing will be reviewed to determine...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years (having passed 18th birthday using Western calendar)
- Confirmed HIV infection using National Testing Algorithm
- CD4 ≤100 cells/μL
- Able to provide written informed consent
- Enrolled at and plan to receive ongoing outpatient care at one of the selected study OPCs
Exclusion
- History of prior CM
- Receipt of systemic antifungal medication for more than 4 consecutive weeks within the past 6 months
- Receipt of ART for more than 4 consecutive weeks within the past year
- For CrAg-positive patients only: Known to be currently pregnant or planning to become pregnant during the study period
Key Trial Info
Start Date :
August 14 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2018
Estimated Enrollment :
1184 Patients enrolled
Trial Details
Trial ID
NCT03267407
Start Date
August 14 2015
End Date
March 31 2018
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital for Tropical Diseases
Hanoi, Vietnam, 100000